Diabetes drug will be a new hope to deal with Alzheimer’s

A drug called semaglutide, commonly used to treat type 2 diabetes and weight loss, may serve as a new weapon against Alzheimer’s disease, a new study suggests.

According to Tekna Technology Media Health and Medical News Service, researchers at Case Western Reserve University of Medicine have discovered that diabetic patients who use semaglutide have a much lower risk of Alzheimer’s disease compared to people who use other diabetes drugs. Alzheimer’s disease is a progressive brain disorder that gradually affects a person’s memory, thinking and abilities. Millions of people around the world are suffering from this disease and there is no definitive cure for it.

By affecting certain receptors in the body, semaglutide helps regulate blood sugar and reduces appetite. In addition to treating diabetes, this drug seems to have a positive effect on the brain. A new study shows that diabetic patients who use semaglutide have a significantly reduced risk of developing Alzheimer’s disease. This finding is very promising and can be considered as an important step towards the treatment of Alzheimer’s disease. However, the researchers emphasize that this study is only an initial step and more research is needed to confirm these findings. Also, this study does not show that semaglutide directly prevents Alzheimer’s.

If the results of subsequent studies confirm this finding, semaglutide can be used as a new and effective treatment to prevent or slow the progression of Alzheimer’s disease. This promising discovery is an important step in the fight against this deadly disease. To see the latest news, refer to the scientific news page of Tekna Media.